Checkpoint Therapeutics, Inc.
USD4.26
+0.00 (+0.00%)
CEO
James F. Oliviero III,
IPO Date
2016-12-19
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.24
Prev. Close
$4.26
Day Low
$4.24
Day High
$4.26
52W Low
$1.80
52W High
$4.50
Market Cap
$0.37B
Volume
8.63M
| -0.8 |
| 31 Dec 2022 | FY | -25850.5% | -32616.7% | 321.4% | -471.2% | 0.00 | 0.41 | -0.7 |
| 31 Dec 2021 | FY | -17979.5% | -21125.7% | -190.3% | -101.6% | 0.00 | 2.14 | -4.2 |
| 31 Dec 2020 | FY | -1429.7% | -2159.1% | -65.2% | -54.2% | 0.00 | 5.90 | -6.4 |
| 31 Dec 2019 | FY | -1031.4% | -1447.0% | -131.1% | -91.6% | 0.00 | 3.32 | -2.5 |
| 31 Dec 2018 | FY | -859.9% | -1037.3% | -308.0% | -146.1% | 0.00 | 1.90 | -1.4 |
| 31 Dec 2017 | FY | -1006.1% | -1314.6% | -150.8% | -105.9% | 0.00 | 3.36 | -3.9 |
| 31 Dec 2016 | FY | -688.6% | -874.0% | -69.5% | -62.4% | 0.00 | 9.80 | -7.7 |
| 31 Dec 2015 | FY | -1819.2% | -2354.6% | -29.9% | -27.4% | 0.05 | 28.30 | -8.8 |
| -1.1 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | 77.2% | -187.8% | 0.00 | 0.29 | -2.5 |
| 30 Jun 2024 | Q2 | -10826.8% | -16268.3% | 42.4% | -117.6% | 0.00 | 0.26 | -2.8 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | 106.8% | -91.4% | 0.00 | 0.54 | -1.5 |
| 31 Dec 2023 | Q4 | 100.0% | -318800.0% | 146.6% | -355.7% | 0.00 | 0.29 | -0.8 |
| 30 Sept 2023 | Q3 | -17629.0% | -18464.5% | 30.1% | -258.1% | 0.00 | 0.10 | -1.5 |
| 30 Jun 2023 | Q2 | -44883.9% | -53293.5% | 71.0% | -198.1% | 0.00 | 0.26 | -0.6 |
| 31 Mar 2023 | Q1 | -45117.1% | -8185.7% | 12.9% | -48.6% | 0.00 | 0.21 | -2.3 |
| 31 Dec 2022 | Q4 | -19137.8% | -34277.0% | 130.2% | -190.9% | 0.00 | 0.41 | -0.5 |